These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37523366)

  • 21. A Three Month Home Exercise Programme Augmented with Nordic Poles for Patients with Intermittent Claudication Enhances Quality of Life and Continues to Improve Walking Distance and Compliance After One Year.
    Oakley C; Spafford C; Beard JD
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):704-709. PubMed ID: 28365377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
    Klaassen-Dekker A; Drossaert CHC; Van Maaren MC; Van Leeuwen-Stok AE; Retel VP; Korevaar JC; Siesling S;
    BMC Cancer; 2023 Nov; 23(1):1112. PubMed ID: 37964214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing walking in patients with intermittent claudication: protocol for a randomised controlled trial.
    Cunningham MA; Swanson V; O'Carroll RE; Holdsworth RJ
    BMC Cardiovasc Disord; 2010 Oct; 10():49. PubMed ID: 20929555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervised exercise therapy for intermittent claudication in daily practice.
    Kruidenier LM; Nicolaï SP; Hendriks EJ; Bollen EC; Prins MH; Teijink JA
    J Vasc Surg; 2009 Feb; 49(2):363-70. PubMed ID: 19028059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences following supervised exercise therapy in patients with intermittent claudication.
    Gommans LN; Scheltinga MR; van Sambeek MR; Maas AH; Bendermacher BL; Teijink JA
    J Vasc Surg; 2015 Sep; 62(3):681-8. PubMed ID: 26304482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.
    Fakhry F; Spronk S; van der Laan L; Wever JJ; Teijink JA; Hoffmann WH; Smits TM; van Brussel JP; Stultiens GN; Derom A; den Hoed PT; Ho GH; van Dijk LC; Verhofstad N; Orsini M; van Petersen A; Woltman K; Hulst I; van Sambeek MR; Rizopoulos D; Rouwet EV; Hunink MG
    JAMA; 2015 Nov; 314(18):1936-44. PubMed ID: 26547465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication.
    King S; Vanicek N; Mockford KA; Coughlin PA
    Clin Biomech (Bristol, Avon); 2012 Oct; 27(8):845-51. PubMed ID: 22663776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wearable Activity Monitors in Home Based Exercise Therapy for Patients with Intermittent Claudication: A Systematic Review.
    Chan C; Sounderajah V; Normahani P; Acharya A; Markar SR; Darzi A; Bicknell C; Riga C
    Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):676-687. PubMed ID: 33451865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of supervised exercise training on walking capacity and quality of life in patients with intermittent claudication.
    Keo H; Grob E; Guggisberg F; Widmer J; Baumgartner I; Schmid JP; Kalka C; Saner H
    Vasa; 2008 Aug; 37(3):250-6. PubMed ID: 18690592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study.
    Dörenkamp S; Mesters I; de Bie R; Teijink J; van Breukelen G
    PLoS One; 2016; 11(1):e0146828. PubMed ID: 26751074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and implementation of SHared decision-making supported by OUTcome information among patients with breast cancer, stroke and advanced kidney disease: SHOUT study protocol of multiple interrupted time series.
    Hackert MQN; Ankersmid JW; Engels N; Prick JCM; Teerenstra S; Siesling S; Drossaert CHC; Strobbe LJA; van Riet YEA; van den Dorpel RMA; Bos WJW; van der Nat PB; van den Berg-Vos RM; van Schaik SM; Garvelink MM; van der Wees PJ; van Uden-Kraan CF;
    BMJ Open; 2022 Aug; 12(8):e055324. PubMed ID: 35914919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based.
    Bendermacher BL; Willigendael EM; Nicolaï SP; Kruidenier LM; Welten RJ; Hendriks E; Prins MH; Teijink JA; de Bie RA
    J Vasc Surg; 2007 Jun; 45(6):1192-6. PubMed ID: 17543684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editor's choice--The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis.
    Gommans LN; Saarloos R; Scheltinga MR; Houterman S; de Bie RA; Fokkenrood HJ; Teijink JA
    Eur J Vasc Endovasc Surg; 2014 Aug; 48(2):169-84. PubMed ID: 24928167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of transcutaneous electrical nerve stimulation on the improvement of walking distance in patients with peripheral arterial disease with intermittent claudication: study protocol for a randomised controlled trial: the TENS-PAD study.
    Besnier F; Sénard JM; Grémeaux V; Riédel M; Garrigues D; Guiraud T; Labrunée M
    Trials; 2017 Aug; 18(1):373. PubMed ID: 28797281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing supervised exercise therapy for patients with intermittent claudication.
    Nicolaï SP; Hendriks EJ; Prins MH; Teijink JA;
    J Vasc Surg; 2010 Nov; 52(5):1226-33. PubMed ID: 20692797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication.
    Lewis RJ; Connor JT; Teerlink JR; Murphy JR; Cooper LT; Hiatt WR; Brass EP
    Trials; 2011 May; 12():134. PubMed ID: 21612611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter randomized controlled study to evaluate whether neuromuscular electrical stimulation improves the absolute walking distance in patients with intermittent claudication compared with best available treatment.
    Lawton R; Babber A; Braithwaite B; Burgess L; Burgess LJ; Chetter I; Coulston J; Epstein D; Fiorentino F; Gohel M; Heatley F; Hinchliffe R; Horgan S; Pal N; Shalhoub J; Simpson R; Stansby G; Davies AH
    J Vasc Surg; 2019 May; 69(5):1567-1573. PubMed ID: 30792054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication.
    Nicolaï SP; Teijink JA; Prins MH;
    J Vasc Surg; 2010 Aug; 52(2):348-55. PubMed ID: 20478681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of exercise on fitness and performance-based tests of function in intermittent claudication: a systematic review.
    Parmenter BJ; Raymond J; Fiatarone Singh MA
    Sports Med; 2013 Jun; 43(6):513-24. PubMed ID: 23539309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK; Geroulakos G; Nicolaides AN
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.